Sinovac Biotech Ltd

SVQ

Company Profile

  • Business description

    Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

  • Contact

    No.39, Shangdi Xi Road
    Haidan District
    Beijing100085
    CHN

    T: +86 1082799800

    E: [email protected]

    http://www.sinovac.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    2,602

Stocks News & Analysis

stocks

Undervalued REIT receives offer from PE firm

Our analysts’ view on the value of the unsolicited offer.
stocks

Apple: With launch of foldable iPhone duo things look twice as nice

We’ve raised our fair value estimate of Apple stock.
stocks

What did Morningstar subscribers buy and sell during August?

Earnings season fuels trading activity.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,920.2013.800.15%
CAC 408,179.7763.010.78%
DAX 4025,568.56207.410.82%
Dow JONES (US)52,573.29509.190.98%
FTSE 10010,650.4441.520.39%
HKSE24,805.63148.84-0.60%
NASDAQ26,333.04251.310.96%
Nikkei 22564,011.341,259.61-1.93%
NZX 50 Index13,580.33130.68-0.95%
S&P 5007,656.9865.280.86%
S&P/ASX 2008,741.2023.300.27%
SSE Composite Index3,888.1146.29-1.18%

Market Movers